IL91638A - Synergistic pharmaceutical compositions containing2,6-dialkyl-3-(esterified carboxyl) 1,4-dihydro-4-phenyl-5-pyridylcarboxylic acid esters of 1,4:3,6-dianhydrohexitols and glyceryl or isosorbide nitrates - Google Patents

Synergistic pharmaceutical compositions containing2,6-dialkyl-3-(esterified carboxyl) 1,4-dihydro-4-phenyl-5-pyridylcarboxylic acid esters of 1,4:3,6-dianhydrohexitols and glyceryl or isosorbide nitrates

Info

Publication number
IL91638A
IL91638A IL9163889A IL9163889A IL91638A IL 91638 A IL91638 A IL 91638A IL 9163889 A IL9163889 A IL 9163889A IL 9163889 A IL9163889 A IL 9163889A IL 91638 A IL91638 A IL 91638A
Authority
IL
Israel
Prior art keywords
ism
gmn
compound
general formula
gtn
Prior art date
Application number
IL9163889A
Other languages
English (en)
Other versions
IL91638A0 (en
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Publication of IL91638A0 publication Critical patent/IL91638A0/xx
Publication of IL91638A publication Critical patent/IL91638A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
IL9163889A 1988-09-20 1989-09-14 Synergistic pharmaceutical compositions containing2,6-dialkyl-3-(esterified carboxyl) 1,4-dihydro-4-phenyl-5-pyridylcarboxylic acid esters of 1,4:3,6-dianhydrohexitols and glyceryl or isosorbide nitrates IL91638A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3831949A DE3831949A1 (de) 1988-09-20 1988-09-20 Arzneimittel

Publications (2)

Publication Number Publication Date
IL91638A0 IL91638A0 (en) 1990-04-29
IL91638A true IL91638A (en) 1994-05-30

Family

ID=6363342

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9163889A IL91638A (en) 1988-09-20 1989-09-14 Synergistic pharmaceutical compositions containing2,6-dialkyl-3-(esterified carboxyl) 1,4-dihydro-4-phenyl-5-pyridylcarboxylic acid esters of 1,4:3,6-dianhydrohexitols and glyceryl or isosorbide nitrates

Country Status (15)

Country Link
US (1) US5254570A (de)
EP (1) EP0361156B1 (de)
JP (1) JPH0643307B2 (de)
KR (1) KR900004743A (de)
AT (1) ATE86487T1 (de)
CA (1) CA1331568C (de)
DD (1) DD284601A5 (de)
DE (2) DE3831949A1 (de)
DK (1) DK461089A (de)
ES (1) ES2053892T3 (de)
FI (1) FI894424L (de)
HU (1) HUT52384A (de)
IE (1) IE892992L (de)
IL (1) IL91638A (de)
PT (1) PT91736B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8003811B2 (en) 2008-02-07 2011-08-23 Nicox S.A. Nitric oxide donor compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2454807A1 (fr) * 1979-04-25 1980-11-21 Laleuf Sa Expl Laboratoires Nouveau medicament constitue par l'association de dinitrate d'isosorbide et de trinitroglycerine
DE3248548A1 (de) * 1982-12-29 1984-07-05 Heinrich Mack Nachf., 7918 Illertissen Acylderivate von 1,4:3,6-dianhydro-hexiten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3523544A1 (de) * 1985-07-02 1987-01-15 Bayer Ag Nifedipin kombinationspraeparat
DE3523540A1 (de) * 1985-07-02 1987-01-15 Bayer Ag Dihydropyridin kombinationspraeparat

Also Published As

Publication number Publication date
DE68905278T2 (de) 1993-06-17
ATE86487T1 (de) 1993-03-15
US5254570A (en) 1993-10-19
JPH0643307B2 (ja) 1994-06-08
PT91736A (pt) 1990-03-30
FI894424A7 (fi) 1990-03-21
HUT52384A (en) 1990-07-28
KR900004743A (ko) 1990-04-12
CA1331568C (en) 1994-08-23
PT91736B (pt) 1995-05-31
EP0361156A3 (en) 1990-04-18
EP0361156B1 (de) 1993-03-10
DD284601A5 (de) 1990-11-21
FI894424L (fi) 1990-03-21
DE68905278D1 (de) 1993-04-15
IL91638A0 (en) 1990-04-29
EP0361156A2 (de) 1990-04-04
DK461089A (da) 1990-03-21
FI894424A0 (fi) 1989-09-19
JPH02160790A (ja) 1990-06-20
IE892992L (en) 1990-03-20
ES2053892T3 (es) 1994-08-01
DE3831949A1 (de) 1990-03-22
DK461089D0 (da) 1989-09-19

Similar Documents

Publication Publication Date Title
IL316473A (en) New methylquinazolinone derivatives
GB2143532A (en) 1,-5 benzothiazepine derivatives, their preparation and pharmaceutical compositions containing them
DK164638B (da) Kombinationspraeparat af pyrimido-pyrimidiner og acetylsalicylsyre og/eller deres farmaceutisk acceptable salte, fremgangsmaade til dets fremstilling samt anvendelse af pyrimido-pyrimidiner og acetylsalicylsyre og/eller salte deraf sammen med farmaceutiske baerere til fremstilling af et kombinationspraeparat
US4886820A (en) Dihydropyridine combination product comprising a dihydropyridine compound and a cardioactive nitrate
US4859665A (en) Antihypertensive combination products containing a dihydropyridine and a pyridazodiazepine
IL91638A (en) Synergistic pharmaceutical compositions containing2,6-dialkyl-3-(esterified carboxyl) 1,4-dihydro-4-phenyl-5-pyridylcarboxylic acid esters of 1,4:3,6-dianhydrohexitols and glyceryl or isosorbide nitrates
US4617306A (en) Pharmaceutical preparation comprising co-dergocrine and a calcium antagonist
SK11695A3 (en) Use of 3-benzoyl-3,7-diazobicyclo£3,3,1| nonane compounds as antiarhytmic effective medicament and method of its production
US4177291A (en) Compounds having antidepressive activity
US4954347A (en) Long lasting composition of propafenone and quinidine for treatment of cardiac conditions
JP2838282B2 (ja) 血管攣縮治療剤
AU781333B2 (en) 3-phenyl-3, 7-diazabicyclo (3.3.1) nonane compounds and process for their preparation and medicaments containing these compounds
Krzemiński et al. Differential effects of furnidipine and its active metabolites in rat isolated working heart
KR960005145B1 (ko) 고혈압 및 울혈성 심부전증 치료용 약학적 조성물
JPS6216417A (ja) 虚血性心疾患・不整脈治療・予防剤
WO2007139497A1 (en) Levoglucosenone derivatives for the treatment of disorders such as cancer, autoimmune diseases and heart diseases.
KR800001144B1 (ko) 2-(4-페닐-4-시아노부틸)-1,2,3,4-테트라하이드로-5(H)-피리도-[4,3-b]-인돌의 제조방법
JPH04145023A (ja) ヒダントイン誘導体を有効成分とする循環器系疾患の予防及び治療剤
JPS59193884A (ja) 1,4−ジヒドロピリジン誘導体
HK40074142A (en) New methylquinazolinone derivatives
JPH07116040B2 (ja) 心臓および神経保護剤
EP0358665A1 (de) Pharmazeutische zusammenstellungen mit spasmolytischer aktivität
JPS6019768A (ja) メチルレバロルフアニウム塩化合物およびその製造方法並びに薬剤
JPS58174324A (ja) 線溶促進剤
JPH05279253A (ja) 骨粗鬆症予防および治療剤

Legal Events

Date Code Title Description
RH Patent void